000 | 00946nam a2200265zi 4500 | ||
---|---|---|---|
005 | 20200314100504.0 | ||
008 | 070917s2007 xxua 000 0 eng | ||
020 | _a0849392195 (encuadernado en tela : papel alcalino) | ||
020 | _a9780849392191 (encuadernado en tela : papel alcalino) | ||
020 | _a1420008900 | ||
020 | _a9781420008906 | ||
035 | _aMX001001114433 | ||
040 |
_aDNLM/DLC _bspa _cDLC _dYDX _dNLM _dBAKER _dUKM _dBTCTA _dYDXCP _dDLC _dUNAMX |
||
050 | 0 |
_aRS431.A64 _bT48 |
|
082 | 0 | 0 |
_a616.99/4061 _222 |
100 | 1 |
_aThurston, David E., _eautor |
|
245 | 1 | 0 |
_aChemistry and pharmacology of anticancer drugs / _cDavid E. Thurston |
264 | 1 |
_aBoca Raton, Florida : _bCRC Press/Taylor & Francis, _cc2007 |
|
300 |
_a290 páginas : _bilustraciones |
||
650 | 0 | _aAgentes antineoplásicos | |
336 |
_atexto _2rdacontent |
||
337 |
_asin medio _2rdamedia |
||
338 |
_avolumen _2rdacarrier |
||
999 |
_c12283 _d12283 |